Here are this week’s most popular tweets from the @F1000 feed, as well as some other interesting picks from Twitter…
“Again, they did it again! As with their other websites, it’s obvious that the F1000 crew puts a lot of thought into making F1000Trials an easy-to-use resource with a lot of helpful features. I’m sitting here clapping my hands,” said Donatas Zailskas, a 6th year medical Lithuanian student. But what do you think about F1000Trials?…
Here are this week’s top tweets from @F1000, as well the other interesting stories we spotted on Twitter…
Ian Beales is a Clinical Senior Lecturer in Cell Biology and Gastroenterology at the University of East Anglia. He has published several papers in F1000Research, and is taking full advantage of the fact that we publish all sound science – not necessarily only large groundbreaking research projects. In this interview, he talks about the work he…
In a recent Industry Forum report by Thomson Reuters, several pertinent statements were made: The growing accumulation of data produced by academics which is not destined for publication represents an impediment to scientific progress. Conventional research assessment methods do not recognise or reward data sharing. A researcher’s overall contribution to scientific progress is greater than…
Here are this week’s most popular tweets from the @F1000 feed, as well as some other interesting picks from Twitter…
For nearly 300 years, peer review has been the main arbiter of regulating scientific quality and maintaining academic integrity. Articles have to be evaluated and satisfy appointed reviewers before they are rubber-stamped into the scientific record, so peer review is unquestionably an indispensable step of the publishing process. As we know ‘peers’ are fellow scientists:…
A few weeks ago, a group of Georgetown, McDonough School of Business MBAs contacted F1000Research to ask about our ongoing campaign to encourage the publication of negative results. They’re trying to develop a way to make it easier for researchers to share negative data. Below, you can find out more about the project from Dennis…
Today, BioMed Central announced that they will require authors to make all data associated with published articles available under a Creative Commons CC0 waiver. This is great news, as it places more biomedical data in the public domain, helping others to reuse data from peer-reviewed papers more efficiently. It’s the same legal tool that our…
Here are this week’s most popular tweets from the @F1000 feed, as well as some other interesting picks from Twitter…
